| # | Side effect | Count |
|---|---|---|
| 0 | OFF LABEL USE | 687 |
| 1 | CYTOMEGALOVIRUS INFECTION REACTIVATION | 293 |
| 2 | CYTOMEGALOVIRUS INFECTION | 262 |
| 3 | DRUG INEFFECTIVE | 251 |
| 4 | MUCOSAL INFLAMMATION | 243 |
| 5 | ADENOVIRUS INFECTION | 240 |
| 6 | PRODUCT USE IN UNAPPROVED INDICATION | 228 |
| 7 | ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 213 |
| 8 | GRAFT VERSUS HOST DISEASE IN SKIN | 168 |
| 9 | ACUTE GRAFT VERSUS HOST DISEASE | 139 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME | 4 | 0.6667 |
| 1 | LUNG DISEASE INFECTIVE EXACERBATION | 16 | 0.5926 |
| 2 | BACILLE CALMETTE-GUERIN SCAR REACTIVATION | 7 | 0.5833 |
| 3 | ADENOVIRUS REACTIVATION | 53 | 0.3681 |
| 4 | HEPATIC IRON OVERLOAD | 6 | 0.2609 |
| 5 | SPLENIC CANDIDIASIS | 6 | 0.2609 |
| 6 | TRANSFUSION MICROCHIMERISM | 2 | 0.2500 |
| 7 | JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA | 10 | 0.1961 |
| 8 | ACUTE GRAFT VERSUS HOST DISEASE ORAL | 6 | 0.1935 |
| 9 | PERINEAL ULCERATION | 27 | 0.1929 |